A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:June 6, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast CancerLast Updated:June 6, 2018Completed
Condition(s):Breast CancerLast Updated:February 17, 2020Completed
Condition(s):Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IV Breast Cancer; Triple-Negative Breast CarcinomaLast Updated:March 19, 2024Completed
Condition(s):Bipolar Disorder; Mania; Schizoaffective DisorderLast Updated:October 24, 2008Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 9, 2019Completed
Condition(s):Breast NeoplasmsLast Updated:March 30, 2012Terminated
Condition(s):Stage IV Lung CancerLast Updated:January 8, 2021Completed
Condition(s):Postmenopausal Women With Advanced Breast CancerLast Updated:February 23, 2017Completed
Condition(s):Breast CancerLast Updated:February 7, 2017Completed
Condition(s):Breast CancerLast Updated:July 18, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.